• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through February 2026 

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through February 2026 

by Truveta Research | Mar 17, 2026 | Featured research, Research, Research Insights

Respiratory virus-associated hospitalizations declined slightly in February 2026 to 3.6% of all hospitalizations. Among children aged 0-4 years, respiratory virus-associated hospitalizations increased slightly to 4.3% of all hospitalizations, with the increase driven...
CDC publishes national COVID-19 analysis using Truveta Data

CDC publishes national COVID-19 analysis using Truveta Data

by Truveta staff | Feb 25, 2026 | Featured research, Research

Older adults remain at highest risk for COVID-19–related hospitalization. Yet a new CDC analysis suggests that effective antiviral treatments are likely underprescribed among outpatients aged 65 or older, with prescribing patterns varying alongside disease...
Early uptake of oral semaglutide for obesity (Wegovy pill) following FDA approval

Early uptake of oral semaglutide for obesity (Wegovy pill) following FDA approval

by Truveta Research | Feb 11, 2026 | Featured research, Research

A large proportion of early users (36.1%) of oral semaglutide (Wegovy pill) had no prior evidence of GLP-1-based medication use, suggesting rapid uptake among patients new to taking GLP-1 medications. Among patients who previously used a GLP-1-based medication, most...

Share this


Recent posts

  • Real-time monitoring of respiratory virus-associated hospitalizations: Trends through February 2026 
  • Linking patient records at scale: New hybrid approach from Truveta
  • Accelerating clinical trial recruitment: From feasibility analysis to site activation

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.